Horizon Discovery plcの内部者の所有権
Horizon Discovery plcの内部者の所有権は何ですか。
Horizon Discovery Group plcの内部者の所有権は10.47%です。
内部者の所有権の定義は何ですか。
管理の所有権(Insider Ownership)は、発行済株式総数で除したインサイダー（5％超を所有する株主または取締役または役員) が所有する株式総数によって計算されます。
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
LSEのセクタHealth Careにおける内部者の所有権の企業と比べるHorizon Discovery plc
Horizon Discovery plcは何をしますか。
Horizon Discovery Group plc, a cell engineering company, engages in the design, manufacture, and application of gene editing and gene modulation tools in the United Kingdom, the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company operates through Screening, Research Reagents, Diagnostics, and BioProduction segments. It provides custom-made and off-the-shelf (OTS) RNAi gene modulation reagents, CRISPR reagents, synthetic SGRNAs, OTS cell models, and custom cell engineering services. The company also offers pooled CRISPR screens; arrayed RNAi and CRISPR screens, drug screens, and immunology assays; and RNAi and CRISPR screening libraries; and human T-Cell CRISPR screening service to meet the requirements of immunology based research in drug discovery. In addition, it provides OTS gene-edited CHO cells and custom CHO cell lines, and custom CHO gene engineering services; and OTS cell-based reference standards, made to order reference standards, and custom cell-based reference standards to evaluate molecular assays on a research use basis. The company serves customers in academic research labs, biopharmaceutical and diagnostics companies, and contract research and manufacturing organizations. It sells its products through direct field sales channel and e-commerce platform. The company has a partnership with the Rutgers, The State University of New Jersey to develop and commercialize base editing, a gene editing technology; strategic collaboration with Mammoth Biosciences to develop CRISPR tools to provide engineered cell lines for the biopharmaceutical industry; and collaboration with St George's University Hospital, London, and the European Molecular Genetics Quality Network to develop reference material for non-invasive prenatal testing. Horizon Discovery Group plc was founded in 2007 and is headquartered in Cambridge, the United Kingdom.
Horizon Discovery plcと類似の内部者の所有権
- BSquare Corpの内部者の所有権は10.46%です。
- Slate Office REITの内部者の所有権は10.46%です。
- Asure Software Incの内部者の所有権は10.46%です。
- Letho Resourcesの内部者の所有権は10.46%です。
- Aura Resourcesの内部者の所有権は10.46%です。
- Vicinity Motorの内部者の所有権は10.47%です。
- Horizon Discovery plcの内部者の所有権は10.47%です。
- Cass Information Systems Incの内部者の所有権は10.48%です。
- Stratabound Minerals Corpの内部者の所有権は10.48%です。
- Stratabound Mineralsの内部者の所有権は10.48%です。
- Naked Brandの内部者の所有権は10.49%です。
- Sonoroの内部者の所有権は10.50%です。
- Hurricane Plcの内部者の所有権は10.50%です。